Last update 11 Oct 2025

DCBCI-0901

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
DCBCI 0901, DCBCI0901, MTR 393
+ [1]
Target
PI3Kα x mTORC1 x mTORC2
Action
inhibitors
Mechanism
PI3Kα inhibitors(Phosphatidylinositol 3 kinase alpha inhibitors), mTORC1 inhibitors(Mammalian target of Rapamycin (mTORC1) inhibitors), mTORC2 inhibitors(mTOR Complex 2 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Advanced Malignant Solid NeoplasmNeoplasms
Originator Organization
Standard Chemical & Pharmaceutical Co., Ltd.Standard Chemical & Pharmaceutical Co., Ltd.
Active Organization-
Inactive Organization
Development Center for BiotechnologyDevelopment Center for BiotechnologyStandard Chemical & Pharmaceutical Co., Ltd.Standard Chemical & Pharmaceutical Co., Ltd.
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with DCBCI-0901
NCT02151357
/ TerminatedPhase 1
Phase I, Sequential Dose Escalation Clinical Study to Investigate the Safety, Tolerability and Pharmacokinetics of in Patients With Advanced Solid Tumor
100 Clinical Results associated with DCBCI-0901
Login to view more data
100 Translational Medicine associated with DCBCI-0901
Login to view more data
100 Patents (Medical) associated with DCBCI-0901
Login to view more data
100 Deals associated with DCBCI-0901
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
Taiwan Province
Standard Chemical & Pharmaceutical Co., Ltd.Standard Chemical & Pharmaceutical Co., Ltd.
19 Aug 2014
NeoplasmsPreclinical
Taiwan Province
Development Center for BiotechnologyDevelopment Center for Biotechnology
01 Nov 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free